Next Article in Journal
PKIB, a Novel Target for Cancer Therapy
Next Article in Special Issue
Expression and Localization Profiles of Tight Junction Proteins in Immune Cells Depend on Their Activation Status
Previous Article in Journal
Rpt5-Derived Analogs Stimulate Human Proteasome Activity in Cells and Degrade Proteins Forming Toxic Aggregates in Age-Related Diseases
Previous Article in Special Issue
Claudin-10 Expression and the Gene Expression Pattern of Thick Ascending Limb Cells
 
 
Article
Peer-Review Record

Altered Sweat Composition Due to Changes in Tight Junction Expression of Sweat Glands in Cholinergic Urticaria Patients

Int. J. Mol. Sci. 2024, 25(9), 4658; https://doi.org/10.3390/ijms25094658
by Denisa Daci 1,†, Sabine Altrichter 2,3,4,5,*,†, François Marie Grillet 2,3, Selma Dib 1, Ahmad Mouna 1, Sukashree Suresh Kumar 1, Dorothea Terhorst-Molawi 2,3, Marcus Maurer 2,3, Dorothee Günzel 1,‡ and Jörg Scheffel 2,3,*,‡
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3: Anonymous
Int. J. Mol. Sci. 2024, 25(9), 4658; https://doi.org/10.3390/ijms25094658
Submission received: 19 February 2024 / Revised: 15 April 2024 / Accepted: 20 April 2024 / Published: 25 April 2024
(This article belongs to the Special Issue The Tight Junction and Its Proteins: From Structure to Pathologies)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

The authors investigated the sweating abnormality of patients with cholinergic urticaria. They collected sweat from patients and healthy individuals and obtained skin biopsies. The concentration of K+ was increased and immunostainings of claudin-3 and claudin-10b were altered in patients. The results are interesting and valuable because they were obtained from clinical samples. The sweat provocation model in isolated skin is also an interesting part of the report.

 

I have several minor comments:

1. Please avoid using abbreviations without explanation. “CholU” should be spelled out in the title, also FFPE and TJ in the abstract.

2. Was there any correlation with age?

3. Indicate in Figures (legends) 2, 5 and 7 how many biological replicates were investigated. Are representatives images shown? How much variability was observed?

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

Comments and Suggestions for Authors

1.     How were CholU diagnosed in patients ?

2.     Dermcidin staining interpretation (Figure 1) : how can you conclude that a decrease of dermcidin staining corresponds to a decrease of whole sebum secretion ? It might be possible that the production of dermcidin is decreased without a decrease of the volume of sebum secretion.

3.     Figures 1 and 2 : without a counter-staining the pictures are difficult to interpret. The differences between patients and controls appear not significant.

4.     Figure 6a : if carbachol was used to stimulate sweat secretion, then replace "Acetylcholine" by "Carbachol".

5.     Replace "dermicidin" by "dermcidin" everywhere in the text.

6.     Finally, the data are not really convincing. In the discussion several hypotheses and possible mechanisms are described, but they are not supported by the data.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 3 Report

Comments and Suggestions for Authors

This is unique study.Well-wrtten and doccumented.

1.It will be nice to have western blot analysis of expression od TJ proteins

2.add study limitations

 

Author Response

Please see the attachment

Author Response File: Author Response.docx

Round 2

Reviewer 2 Report

Comments and Suggestions for Authors

The authors made several changes in the text and added new data (Figure 2d-f), rendering the paper more understandable.

The field of Figure 1 is too small to ensure that there is no leakage of dermcidin in surrounding sebaceous glands. The Figure 1 is so not really convincing.

Back to TopTop